文献
J-GLOBAL ID:202102231002812649
整理番号:21A0093518
上皮増殖因子受容体変異を伴う医学的に手術不能およびチロシンキナーゼ阻害剤未投与早期肺腺癌の管理:後ろ向き多施設解析【JST・京大機械翻訳】
Management of medically inoperable and tyrosine kinase inhibitor-naieve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis
著者 (24件):
Sun Yuemei
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Sun Yuemei
(North Sichuan Medical College, Nanchong, China)
,
Wu Mengwan
(School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Zhou Mingxiu
(School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Luo Xing
(School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Guo Yan
(School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Bai Hansong
(School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Zhang Zican
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Zhang Zican
(North Sichuan Medical College, Nanchong, China)
,
Tian Wei
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Tian Wei
(School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Wang Xiaoshan
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Bai Yifeng
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Zhu Xueqiang
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Pan Haixia
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Deng Ying
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Hu Honglin
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Xia Jianling
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Hao Xinbao
(Sino-America Cancer Center, Hainan Medical University, First Affiliated Hospital of Hainan Medical College, Haikou, China)
,
Han Liangfu
(Cancer Center, BoaoEvergrande International Hospital, Qionghai, Haikou, China)
,
Wei Min
(Cancer Center, Ziyang People’s Hospital, Ziyang, China)
,
Liu Yingyi
(Dept of Radiation Oncology, Sichuan Friendship Hospital, Chengdu, Sichuan, China)
,
Zeng Ming
(Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
,
Zeng Ming
(School of Medicine, University of Electronic Science and Technology of China, Chengdu, China)
資料名:
BMC Cancer (Web)
(BMC Cancer (Web))
巻:
20
号:
1
ページ:
1-9
発行年:
2020年
JST資料番号:
U7305A
ISSN:
1471-2407
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)